Tysabri |
Natalizumab |
Image:Natalizumab.png Natalizumab Systematic (IUPAC) name Humanized anti a4 integrin antibody Identifiers CAS number ? ATC code L04AA23 PubChem ? DrugBank BTD00083 Chemical data Formula ? Mol. weight ? Pharmacokinetic data Bioavailability ? Metabolism ? Half life ? Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Natalizumab is a drug co-marketed by Biogen Idec ...
Wikipedia - [full article]
Tysabri Clinical Trials
- TOP: IMA-06-02 Tysabri Observational Program
ClinicalTrials.gov Identifier: NCT00493298 - Recruiting
Relapsing Remitting Multiple Sclerosis
- The Effects of TYSABRI Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00536120 - Recruiting
Multiple Sclerosis
- Pregnancy Exposure Registry for Tysabri
ClinicalTrials.gov Identifier: NCT00472992 - Recruiting
Pregnancy; Prenatal Exposure Delayed Effects; Multiple Sclerosis

Not Signed In -


